Old Web
English
Sign In
Acemap
>
authorDetail
>
Manjun Li
Manjun Li
University of South Australia
Kinase
Chemistry
Phosphorylation
Cancer
Cyclin-dependent kinase 8
4
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition.
2022
Neoplasia
Melissa K. Bennett
Manjun Li
Melinda N. Tea
Melissa R. Pitman
John Toubia
Paul Wang
Dovile Anderson
Darren J. Creek
Robert Z. Orlowski
Briony L. Gliddon
Jason A. Powell
Craig T. Wallington-Beddoe
Stuart M. Pitson
Show All
Source
Cite
Save
Citations (0)
Potent and orally bioavailable CDK8 inhibitors: Design, synthesis, structure-activity relationship analysis and biological evaluation.
2021
European Journal of Medicinal Chemistry
Mingfeng Yu
Theodosia Teo
Yuchao Yang
Manjun Li
Yi Long
Stephen Philip
Benjamin Noll
Gary K. Heinemann
Sarah Diab
Preethi Eldi
Laychiluh B. Mekonnen
Abel T. Anshabo
Muhammed H. Rahaman
Robert W. Milne
John D. Hayball
Shudong Wang
Show All
Source
Cite
Save
Citations (1)
Discovery of a potent, highly selective, and orally bioavailable inhibitor of CDK8 through a structure-based optimisation.
2021
European Journal of Medicinal Chemistry
Mingfeng Yu
Yi Long
Yuchao Yang
Manjun Li
Theodosia Teo
Benjamin Noll
Stephen Philip
Shudong Wang
Show All
Source
Cite
Save
Citations (0)
Synthesis and evaluation of 2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione derivatives as Mnk inhibitors
2019
Bioorganic & Medicinal Chemistry Letters
Ahmed M. Abdelaziz
Sunita K. C. Basnet
Saiful Islam
Manjun Li
Solomon Tadesse
Hugo Albrecht
Cobus Gerber
Mingfeng Yu
Shudong Wang
Show All
Source
Cite
Save
Citations (4)
1
map